市場調查報告書
商品編碼
1402410
腸外營養市場-按成分(胺基酸、脂肪、碳水化合物、微量元素、維生素、礦物質)、類型(RTU、複合)、消費者(兒童和新生兒、成人)、最終用戶(醫院、診所、家庭護理)與全球2023-2032 年預測Parenteral Nutrition Market-By Composition (Amino Acids, Fats, Carbohydrates, Trace Elements, Vitamins, Minerals), Type (RTU, Compounded), Consumer (Children and Newborns, Adults), End-user (Hospitals, Clinics, Homecare) & Global Forecast 2023-2032 |
在產業領導者產品推出激增的推動下,2023 年至 2032 年間,全球腸外營養市場CAGR將達到 7.1%。大公司引進先進的配方和輸送系統來滿足不同患者的需求。這些創新著重於改善營養成分、增強相容性和降低風險,從而推動市場擴張。
例如,2023 年 10 月,百特韓國推出了 Olimel N12E,這是一種富含蛋白質的全腸外營養 (TPN) 解決方案,專為重症患者量身定做,並由健康保險承保。每 1,000 毫升,Olimel N12E 含有 76 克氨基酸和 950 卡路里,與 Baxter 之前的複合維生素液 Olimel N9E 相比,氨基酸含量顯著增加了 33%。這種增強作用在維持劑量的同時提高了胺基酸含量。有 1,000 mL、1,500 mL、2,000 mL 和更小的 650 mL 規格可供選擇,患者可以靈活地選擇液體容量以滿足其營養需求。
由於這些尖端產品的出現,市場重點關注解決重症監護、腫瘤學和早產兒護理中的營養缺乏問題,從而標誌著滿足全球特殊營養需求的關鍵時代。
腸外營養市場的總體佔有率根據成分、最終用戶和地區進行分類。
從 2023 年到 2032 年,脂肪細分市場將經歷重大發展。脂肪在為無法口服食物的患者提供必需營養素和熱量方面發揮關鍵作用。這些脂質組成提供集中的能量來源,有助於維持健康的身體功能。隨著醫療保健提供者優先考慮客製化營養,腸外營養解決方案中的脂肪對於解決營養不良、支持康復和滿足不同醫療狀況患者的特定飲食需求變得不可或缺。
2023 年至 2032 年,家庭護理機構的腸外營養市場規模將實現顯著的CAGR。無法口服食物的家庭患者可以從客製化的腸外營養解決方案中受益。這些方便的療法可確保患者透過靜脈注射獲得重要的營養物質,從而促進康復並維持健康。隨著醫療保健轉向以患者為中心的家庭護理,對腸外營養的需求不斷增加,使具有複雜醫療需求的個人能夠在舒適的家中獲得必需的營養,提高他們的生活品質並幫助他們康復。
2023年至2032年,歐洲腸外營養產業將呈現出值得稱讚的CAGR。隨著人口老化和慢性病的盛行率上升,對專業營養支持的需求不斷增加。腸外營養對於解決重症監護、營養不良和消化系統疾病變得至關重要。此外,配方和輸注技術的進步也改善了患者的治療效果。隨著歐洲醫療保健系統優先考慮以患者為中心的護理,對客製化腸外營養解決方案的需求不斷增加,反映出滿足整個非洲大陸多樣化營養需求的關鍵時代。
Global Parenteral Nutrition Market will witness 7.1% CAGR between 2023 and 2032, propelled by a surge in product launches by industry leaders. Major companies introducing advanced formulations and delivery systems cater to diverse patient needs. These innovations focus on improved nutrient profiles, enhanced compatibility, and reduced risks, driving market expansion.
For instance, in October 2023, Baxter Korea unveiled Olimel N12E, a protein-rich Total Parenteral Nutrition (TPN) solution tailored for critically ill patients and covered by health insurance. With each 1,000 mL, Olimel N12E packs 76 grams of amino acids and 950 calories, presenting a significant 33 percent boost in amino acids compared to Baxter's prior multivitamin fluid, Olimel N9E. This enhancement maintains dosage while elevating the amino acid content. Available in 1,000 mL, 1,500 mL, 2,000 mL, and a smaller 650 mL size, patients gain flexibility in selecting fluid volumes to match their nutritional needs.
With an emphasis on addressing nutritional deficiencies in critical care, oncology, and premature infant care, the market experiences an upswing due to these cutting-edge offerings, marking a pivotal era in meeting specialized nutritional requirements globally.
The overall Parenteral Nutrition Market share is classified based on the composition, end-user, and region.
Fats segment will undergo significant development from 2023 to 2032. Fats play a pivotal role in providing essential nutrients and calories crucial for patients unable to consume food orally. These lipid-based components offer concentrated energy sources, aiding in the maintenance of healthy body functions. As healthcare providers prioritize tailored nutrition, fats in parenteral nutrition solutions become indispensable for addressing malnutrition, supporting recovery, and meeting the specific dietary needs of patients across diverse medical conditions.
Parenteral nutrition market size from the homecare settings segment will register a noteworthy CAGR from 2023 to 2032. Home-based patients unable to intake food orally benefit from tailored parenteral nutrition solutions. These convenient therapies ensure patients receive vital nutrients intravenously, promoting recovery and sustaining health. As healthcare shifts towards patient-centric homecare, the demand for parenteral nutrition rises, enabling individuals with complex medical needs to receive essential nourishment in the comfort of their homes, enhancing their quality of life and aiding in their recuperation.
Europe parenteral nutrition industry will showcase a commendable CAGR from 2023 to 2032. With an aging population and rising prevalence of chronic conditions, the need for specialized nutritional support amplifies. Parenteral nutrition, addressing critical care, malnutrition, and digestive disorders, becomes vital. Additionally, advancements in formulations and infusion technologies enhance patient outcomes. As European healthcare systems prioritize patient-centric care, the demand for tailored parenteral nutrition solutions rises, reflecting a pivotal era in meeting diverse nutritional needs across the continent.